Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HALOPERIDOL Cause Therapeutic product effect variable? 123 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Therapeutic product effect variable have been filed in association with HALOPERIDOL (Haloperidol). This represents 0.8% of all adverse event reports for HALOPERIDOL.

123
Reports of Therapeutic product effect variable with HALOPERIDOL
0.8%
of all HALOPERIDOL reports
0
Deaths
123
Hospitalizations

How Dangerous Is Therapeutic product effect variable From HALOPERIDOL?

Of the 123 reports, 123 (100.0%) required hospitalization, and 1 (0.8%) were considered life-threatening.

Is Therapeutic product effect variable Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HALOPERIDOL. However, 123 reports have been filed with the FAERS database.

What Other Side Effects Does HALOPERIDOL Cause?

Drug ineffective (1,771) Neuroleptic malignant syndrome (1,244) Off label use (1,136) Toxicity to various agents (872) Extrapyramidal disorder (838) Somnolence (712) Intentional self-injury (636) Drug interaction (596) Weight increased (583) Tremor (579)

What Other Drugs Cause Therapeutic product effect variable?

CARBIDOPA\LEVODOPA (316) LEVODOPA (298) RIMEGEPANT (177) GABAPENTIN (166) CLOZAPINE (157) DICLOFENAC (153) OLANZAPINE (150) FLUOXETINE (149) ARIPIPRAZOLE (148) AMISULPRIDE (147)

Which HALOPERIDOL Alternatives Have Lower Therapeutic product effect variable Risk?

HALOPERIDOL vs HALOPERIDOL DECANOATE HALOPERIDOL vs HECTOROL HALOPERIDOL vs HEMIN HALOPERIDOL vs HEPARIN HALOPERIDOL vs HEPARIN\SODIUM

Related Pages

HALOPERIDOL Full Profile All Therapeutic product effect variable Reports All Drugs Causing Therapeutic product effect variable HALOPERIDOL Demographics